Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

epoc Blood Analysis System

K-Number: K200107 · 2020-06-05

ApplicantEpocal, Inc.
Decision Date2020-06-05
Product CodeCHL
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

epoc Blood Analysis System is a medical device manufactured by Epocal, Inc.. It received FDA 510(k) clearance on 2020-06-05 under approval number K200107. The device is classified under product code CHL. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the epoc Blood Analysis System?

epoc Blood Analysis System is a medical device that received FDA 510(k) clearance on 2020-06-05. It is manufactured by Epocal, Inc.. The 510(k) number is K200107.

When was epoc Blood Analysis System approved by the FDA?

epoc Blood Analysis System received FDA 510(k) clearance on 2020-06-05, under approval number K200107.

What company makes epoc Blood Analysis System?

epoc Blood Analysis System is manufactured by Epocal, Inc..

What is the FDA product code for epoc Blood Analysis System?

The FDA product code for epoc Blood Analysis System is CHL.

Related Clinical Trials

Related PubMed Literature

Other Devices by Epocal, Inc.

Related Devices (Code: CHL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.